Advanced Medical Solutions (LON:AMS) had its target price lifted by Numis Securities from GBX 275 ($3.58) to GBX 320 ($4.17) in a research report report published on Wednesday. The firm currently has a hold rating on the stock.
Shares of LON:AMS opened at GBX 313.50 ($4.08) on Wednesday. Advanced Medical Solutions has a fifty-two week low of GBX 237 ($3.09) and a fifty-two week high of GBX 351 ($4.57).
The firm also recently declared a dividend, which will be paid on Friday, October 26th. Investors of record on Thursday, September 27th will be paid a dividend of GBX 0.42 ($0.01) per share. This represents a yield of 0.14%. The ex-dividend date is Thursday, September 27th.
In related news, insider Mary G. Tavener sold 9,305 shares of the company’s stock in a transaction on Monday, June 25th. The shares were sold at an average price of GBX 327 ($4.26), for a total transaction of £30,427.35 ($39,634.43).
About Advanced Medical Solutions
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes natural and synthetic polymers for use in advanced woundcare dressings worldwide. It operates through Branded Direct, Branded Distributed, Original Equipment Manufacturer, and Bulk Materials segments.
Read More: Hedge Funds Explained
Receive News & Ratings for Advanced Medical Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions and related companies with MarketBeat.com's FREE daily email newsletter.